RBC Life Sciences Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Net Income before Extraordinaries
361.40
500.00
602.80
741.80
756.30
Depreciation, Depletion & Amortization
584.70
588.30
579.90
502.10
414.80
Other Funds
404.70
7.20
2.10
1,706.90
-
Funds from Operations
72.80
139.90
146.00
2,053.70
259.00
Changes in Working Capital
518.20
434.20
461.80
2,198.50
414.50
Net Operating Cash Flow
445.40
294.20
607.70
4,252.20
155.50
Capital Expenditures
805.40
267.10
1,074.40
180.00
148.80
Sale of Fixed Assets & Businesses
-
-
-
4,818.80
-
Net Investing Cash Flow
180.10
267.10
1,074.40
4,638.80
148.80
Issuance/Reduction of Debt, Net
182.10
196.70
212.50
1,136.30
-
Net Financing Cash Flow
182.10
214.60
212.50
1,135.50
-
Net Change in Cash
37.50
150.40
1,824.30
471.50
20.80
Free Cash Flow
360.00
27.20
1,682.20
4,432.20
6.70
Deferred Taxes & Investment Tax Credit
108.60
235.50
125.20
107.20
82.50
Other Sources
625.20
-
-
-
-
Change in Capital Stock
-
17.90
-
0.90
-
Exchange Rate Effect
45.60
37.00
70.30
277.40
14.10
About RBC Life Sciences
View Profile
